Houston, TX, United States of America

Maria I Nunez

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Maria I. Nunez: Pioneering TUSC2 Therapies in Cancer Treatment

Introduction: Maria I. Nunez is a notable inventor based in Houston, Texas, whose groundbreaking work in cancer therapies has the potential to significantly impact patient treatment outcomes. With a focus on TUSC2 therapies, Nunez's innovations aim to enhance the effectiveness of cancer treatments, particularly by predicting patient responses to therapies based on biological markers.

Latest Patents: Nunez's patent is centered around TUSC2 therapies, which include a method for predicting a subject's response to treatment. Specifically, this innovation allows for the prediction based on the proportion of apoptotic cancer cells. The patent not only outlines the prediction methods but also provides a therapeutic approach for those identified to have a favorable response to TUSC2 therapy. Additionally, it discusses the administration of TUSC2 therapeutic agents alongside EGFR inhibitors and protein kinase inhibitors, as well as kits and reagents designed for use in TUSC2 therapy.

Career Highlights: Maria I. Nunez is associated with the University of Texas System, where she contributes to advancing cancer therapies through her research and innovative thinking. Her single patent reflects her dedication to finding novel solutions in the field of cancer treatment, showcasing her commitment to improving patient health.

Collaborations: Throughout her career, Nunez has collaborated with esteemed colleagues such as Jack A. Roth and David J. Stewart. These collaborations highlight the importance of teamwork and shared expertise in driving forward innovative research in the treatment of cancer.

Conclusion: Maria I. Nunez exemplifies the spirit of innovation and dedication to improving cancer therapies through her patented work on TUSC2 therapies. Her contributions not only pave the way for more effective treatment options but also represent the vital role of collaboration in scientific advancement. As research continues, her pioneering efforts promise to enhance the landscape of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…